Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer.

Bellmunt, J; Guillem, V; Paz-Ares, L; González-Larriba, J L; Carles, J; Albanell, J; Tabernero, J M; Cortés-Funes, H; Baselga, J

Bellmunt, J; Guillem, V; Paz-Ares, L; González-Larriba, J L; Carles, J; Albanell, J; Tabernero, J M; Cortés-Funes, H; Baselga, J.

Affiliation

Bellmunt J; Hospital General Universitari Vall d'Hebron, P. Vall d'Hebron 119-129, 08035, Barcelona, Spain. bellmunt@hg.vhebron.es

Eur J Cancer ; 36 Suppl 2: 17-25, 2000 Jul.

Article in En | MEDLINE | ID: mdl-10908844

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Transitional Cell/drug therapy; Urinary Bladder Neoplasms/drug therapy; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell/pathology; Cisplatin/administration & dosage; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide/administration & dosage; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Doxorubicin/administration & dosage; Female; Humans; Male; Methotrexate/administration & dosage; Middle Aged; Paclitaxel/administration & dosage; Urinary Bladder Neoplasms/pathology; Vinblastine/administration & dosage; Gemcitabine

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2000 Type: Article

Search on Google

XML

PubMed Links